Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2002
06/05/2002EP0755386B1 Benzamide derivative, compositions containing said derivative and use thereof
06/05/2002EP0752866B1 Medicaments for treating restenosis, comprising nitric oxide releasing polymers
06/05/2002EP0752851B1 Process for preparing a pharmaceutical formulation
06/05/2002EP0741574B1 Oral dosage form containing colestipol as a carrier and acidic active substances and a process for producing the same
06/05/2002EP0705113B1 Dried hydrogel from acemannan
06/05/2002EP0663951B1 Chitosan matrices for encapsulated cells
06/05/2002EP0632723B1 Use of transglutaminase inhibitor for the treatment of scar tissue
06/05/2002EP0627914B1 Use of butylurea as contraceptive agent
06/05/2002EP0625034B1 Skin adhesive hydrogel, its preparation and uses
06/05/2002CN1352634A Process for preparing amlodipine benzenesulphonate
06/05/2002CN1352568A Water soluble compositions for bioactive lipophilic compounds
06/05/2002CN1352563A Use of phyllanthus for targeted stimulation of the immune system
06/05/2002CN1352560A Ziprasidone suspension
06/05/2002CN1352557A Compositions for improivng fertility
06/05/2002CN1352551A Preparations for the application of anti-inflammatory agents
06/05/2002CN1352550A Acidic buffered nasal spray
06/05/2002CN1352549A Methods and devices for providing prolonged drug therapy
06/05/2002CN1352548A Drinkable ibuprofen pharmaceutical suspension
06/05/2002CN1351887A Externally applied Chinese medicine decoction
06/05/2002CN1351880A Pus drawing out paste for expelling wind and removing obstruction in channels and its preparing method
06/05/2002CN1351871A Compound chlorhexidine cream and its prepairng method
06/05/2002CN1351869A Method for preparing nanometer level pearli powder
06/05/2002CN1351868A Implanted slow-releasing antiseptic preparation and its preparing method
06/05/2002CN1351866A Levo-potassium magnesium aspartate freeze drying powder injection and preparing method
06/05/2002CN1085987C Heterotelechelic block copolymers and process for producing same
06/05/2002CN1085944C Epidural administration therapeutic compounds with sustained rate of release
06/04/2002USRE37727 Applying at the site of pain, a plaster or gel, comprising from about 2-10% by weight of lidocaine at least in part as the free base in a formulation which provides for intradermal transport of said lidocaine,
06/04/2002US6399798 Method of preparing alkylated salicylamides
06/04/2002US6399663 Drug delivery
06/04/2002US6399661 Mixing alkaline powder with powdered creatine until ph is 7-14; powdered additive is added to improve sweetness and taste; finally, further alkaline powder is added to adjust the ph to 7-14.
06/04/2002US6399651 Method of treating dermatoses using avermectin compound
06/04/2002US6399637 Crystal modification of torasemide
06/04/2002US6399610 Nasal or oral treatment of heart failure; reduced occurance of headaches or palpitation
06/04/2002US6399605 Ophthalmic composition comprising a beta -blocker
06/04/2002US6399594 With water insoluble starch carrier; allows dry storage and lower doses of active ingredient
06/04/2002US6399591 Chargeable pharmaceutical tablets
06/04/2002US6399566 Mixture containing capsaicine, histamine or plant extract
06/04/2002US6399341 Artificial pancreas
06/04/2002US6399192 Adhesive plaster with microcapsules containing essences, and method for its preparation
06/04/2002US6399143 Method for clamping and electrostatically coating a substrate
06/04/2002US6399104 Pharmaceutical compositions
06/04/2002US6399103 Dispersing physiologically active polypeptide into biodegradable polymer and zinc oxide; high entrapment ratio; high blood concentration levels over extended period
06/04/2002US6399102 Aerodynamically light particles for pulmonary drug delivery
06/04/2002US6399101 Levothyroxine sodium and silicified microcrystalline cellulose; tablets; light, heat, and humidity stable
06/04/2002US6399100 Controlled release pharmaceutical compositions containing tiagabine
06/04/2002US6399099 Flavone glycosides and terpenoids with citric or tartaric acid or monosodium salt and sodium carbonate or bicarbonate; when dissolved in water almost clear, ph 6-8 and stable for at least one hour
06/04/2002US6399098 Composition for treating dental caries caused by streptococcus mutans
06/04/2002US6399097 Composition for treatment of a bacterial infection of the digestive tract
06/04/2002US6399096 Morphine and other drugs with fillers
06/04/2002US6399095 Aloe leaves, freeze drying and vacuum drying
06/04/2002US6399094 Unilamellar liposomal preparations with high active substance content
06/04/2002US6399090 Insulin supplemented infant formula
06/04/2002US6399087 Dissolving in a solvent, emulsification with water and surfactant
06/04/2002US6399086 Controlled release of drugs in small intestine, polymer matrices
06/04/2002US6399082 Alpha-hydroxy acid, diol and semi-occlusion vehicles
06/04/2002US6399079 Spill resistant pharmaceutical compositions in semi-solid form
06/04/2002US6399058 Methods for treating ocular diseases
06/04/2002US6397849 Methods of ophthalmic administration
06/04/2002US6397840 Dry powder dispensing device
06/04/2002CA2239352C Injectable quinolone formulations
06/04/2002CA2119262C Compositions comprising a bactericidal/permeability increasing protein and a lipid carrier, methods of making same, and uses thereof
06/04/2002CA2103725C Composition for use in transdermal administration
06/04/2002CA2078990C Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
06/04/2002CA2067754C Preparation for the application of agents in mini-droplets
06/03/2002WO2002000202A1 Endoparasiticidal agents for voluntary oral ingestion by animals
06/01/2002CA2325088A1 Novel membrane fusion proteins derived from poikilothermic reovirus
05/2002
05/30/2002WO2002042325A2 Cyp1b1 nucleic acids and methods of use
05/30/2002WO2002041987A2 Polymeric microspheres
05/30/2002WO2002041928A1 Porous polymeric biomaterials, preparation method and uses
05/30/2002WO2002041925A1 Sterilisation of pharmaceuticals
05/30/2002WO2002041920A1 Oral pharmaceutical compositions containing cyclodextrins as taste masking agent
05/30/2002WO2002041919A1 Freeze-dried pantoprazole preparation and pantoprazole injection
05/30/2002WO2002041915A1 A composition of sodium channel blocking compound
05/30/2002WO2002041912A1 Drugs and foods improving the quality of life and process for producing the same
05/30/2002WO2002041910A2 Methods and compositions for the treatment of diseases of the eye
05/30/2002WO2002041900A1 Preparation for strengthening the immune response in the waldeyer's ring and the oronasal mucosa by intranasal administration
05/30/2002WO2002041899A1 An antibiotic/analgesic formulation and a method of making this formulation
05/30/2002WO2002041892A1 Water-soluble liquid internal medicine
05/30/2002WO2002041887A1 Dry syrup preparations
05/30/2002WO2002041884A2 Inhibitors of abc drug transporters at the blood-brain barrier
05/30/2002WO2002041883A2 As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation
05/30/2002WO2002041881A2 Repinotan kit
05/30/2002WO2002041878A2 Titratable dosage transdermal delivery system
05/30/2002WO2002041877A1 Sodium hyaluronate microspheres
05/30/2002WO2002041876A1 Pharmaceutical composition for controlled release of an active ingredient
05/30/2002WO2002041875A2 Method for producing readily soluble medicament formulations and corresponding formulations
05/30/2002WO2002041874A2 Granulation process
05/30/2002WO2002041873A1 Coacervation method for producing time-release medicaments
05/30/2002WO2002041872A1 Generation of therapeutic microfoam
05/30/2002WO2002041871A2 Composition comprising an imexon or derivatives thereof and lipids
05/30/2002WO2002041862A1 An oral hygiene preparation for inhibiting halitosis
05/30/2002WO2002041859A1 Use of cyclosporin a 7-thioamide derivatives for hair growth
05/30/2002WO2002041853A1 O/w emulsion composition and method of preparing the same
05/30/2002WO2002041848A2 Propellant-gas-free spray preparations
05/30/2002WO2002041847A1 Cosmetic or dermatological agent in the form of a creamy permanent mousse or a stable foamed cream
05/30/2002WO2002041844A2 Chemotherapeutic composition using nanocrystalline calcium phosphate paste
05/30/2002WO2002041840A2 Sildenafil citrate chewing gum formulations and methods of using the same
05/30/2002WO2002041837A2 Treatment of mucositis
05/30/2002WO2002041829A2 Oral nanosphere delivery
05/30/2002WO2002041765A2 Biodegradable bioadhesive controlled release system of nano-particles for oral care products